Leg ulcers in sickle cell disease: current patterns and practices

scientific article published on 19 April 2013

Leg ulcers in sickle cell disease: current patterns and practices is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/03630269.2013.789968
P932PMC publication ID3864012
P698PubMed publication ID23600469
P5875ResearchGate publication ID236249234

P50authorGregory J. KatoQ42322791
P2093author name stringKathryn L Hassell
Caterina P Minniti
Catherine Seamon
Patricia E Adams-Graves
Ashley Buscetta
Kara-Marie H Delaney
Karen C Axelrod
P2860cites workInterventions for treating leg ulcers in people with sickle cell diseaseQ24202954
Compression for venous leg ulcersQ24241720
Hyperbaric oxygen therapy for chronic woundsQ24247431
Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910Q24653188
Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetesQ33804804
Leg ulcers in sickle cell diseaseQ34193107
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell AnemiaQ34308407
Larval therapy for leg ulcers (VenUS II): randomised controlled trial.Q34658264
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathwayQ35191429
Leg ulcer in hereditary spherocytosis.Q35548277
Laboratory and echocardiography markers in sickle cell patients with leg ulcersQ35632843
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseQ35849493
Sickle cell anemia and major organ failureQ37804100
Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcersQ39343494
Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjectsQ40108760
Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers.Q40520732
Hydroxyurea and lower leg ulcersQ40791182
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcersQ42855618
Hydroxyurea and sickle cell leg ulcersQ43831735
The natural history of thalassemia intermediaQ45097361
A hemodynamic study of pulmonary hypertension in sickle cell diseaseQ49084691
Excision and meshed skin grafting for leg ulcers resistant to compression therapy.Q51096667
Leg ulcers in sickle cell disease.Q51597006
Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.Q51896675
Pyruvate kinase deficiency and leg ulcersQ54613360
Leg ulcers in patients with sickle cell diseaseQ69093655
Leg Ulceration in Sickle Cell AnemiaQ69744791
Zinc in the healing woundQ71002436
Leg ulcers in sickle cell diseaseQ71861751
Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study GroupQ72175906
Leg ulcers and hydroxyurea: forty-one casesQ78015167
Oral zinc sulphate in sickle-cell ulcersQ93691263
P433issue4
P921main subjectsickle-cell diseaseQ185034
P304page(s)325-332
P577publication date2013-04-19
P1433published inHemoglobinQ15752077
P1476titleLeg ulcers in sickle cell disease: current patterns and practices
P478volume37